Lentinan confers protection against type 1 diabetes by inducing regulatory T cell in spontaneous non-obese diabetic mice.
Tijun WuTing LeiFandi NiuBin QianPeng SunNan YangJing PangHongliang MeiXiaoai ChangFang ChenYunxia ZhuYating LiFu-Gen WuYaqin ZhangTing LeiXiao HanPublished in: Nutrition & diabetes (2023)
LNT was capable of stimulating the production of Treg cells from naive CD4 + T cells, which implies that LNT exhibits therapeutic values as a tolerogenic adjuvant and may be used to reverse hyperglycaemia in the early and late stages of T1D.